Financial comparisons Zhongzhi Pharmaceutical Holdings Limited
Equities
3737
KYG989611085
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6200 HKD | +8.77% |
|
+5.08% | -37.37% |
| 26/08 | Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 18/07 | Zhongzhi pharmaceutical expects 90% decrease in HY net profit | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 615.34Cr | 20.79% | 23.79% | 16.09% | 12.31% | -1.53x | |
| 1.48TCr | 14.73% | 13.89% | 13.4% | 9.46% | -0.55x | |
| 1.04TCr | - | 17.58% | 13.99% | 5.98% | 1.6x | |
| 322.4Cr | 19.14% | 21.86% | 18.21% | 15.04% | -1.12x | |
| 272Cr | 19.47% | 24.78% | 21.44% | 14.12% | 0.03x | |
| 55Cr | 14.99% | 16.11% | 7.27% | 6.06% | -0.96x | |
| 197.7Cr | 18.69% | 22.39% | 16.1% | 12.7% | -0.66x | |
| 325.13Cr | 10.28% | 12.27% | 6.4% | 6% | -0.85x | |
| 155.91Cr | 7.86% | 14% | 16.76% | - | 0.33x | |
| 215.81Cr | 27.9% | 30.45% | 19.68% | 16.14% | -0.36x | |
| 92Cr | 11.05% | 12.78% | 10.26% | 6.56% | -0.74x | |
| 101.24Cr | 8.31% | 14.46% | 11.89% | 6.19% | 1.55x | |
| 54Cr | 19.8% | 24% | 25.02% | 19.07% | -0.48x | |
| 51Cr | - | 20.44% | 5.87% | - | 0.39x | |
| 20Cr | -37.24% | -25.56% | -24.57% | - | - | |
| 82Cr | 19.25% | 21.5% | 25.34% | 13.71% | 0.46x | |
| Average | 317.28Cr | 12.5% | 16.55% | 12.7% | 11.03% | -0.19x | |
| Weighted average by Cap. | 645.24Cr | 16.43% | 18.8% | 14.37% | 10.48% | -0.39x |
- Stock Market
- Equities
- 3737 Stock
- Sector Zhongzhi Pharmaceutical Holdings Limited
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition